Zions Bancorporation, N.A. Jazz Pharmaceuticals PLC Transaction History

Zions Bancorporation, N.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$114.26 - $136.0 $1,028 - $1,224	9 New	9 $1,000
Q4 2022 Feb 10, 2023	BUY	$129.72 - $159.85 $518 - $639	4 New	4 $0
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $2,397 - $2,913	-20 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$128.64 - $184.79 $2,572 - $3,695	20 New	20 $3,000
Q4 2020 Feb 12, 2021	SELL	$140.71 - $165.05 $2,110 - $2,475	-15 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$105.46 - $144.13 $1,581 - $2,161	15 New	15 $2,000
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $3,635 - $4,631	-38 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$121.81 - $142.95 $974 - $1,143	-8 Reduced 17.39%	38 $5,000
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $5,333 - $7,670	46 New	46 $6,000

490

57M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.95B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.